Smisson-Cartledge Biomedical, LLC Announces FDA 501(k) Market Clearance of ThermaCor 1200 Thermal Infusion System
Smisson-Cartledge Biomedical LLC (SCB) announced today U.S. Food and Drug Administration (FDA) market clearance of their ThermaCor 1200 Infusion System, the first full range, portable normothermic infusion system funded in part by the U.S. Military. - April 25, 2007
Press Releases 1 - 1 of 1